From August 30, 2023 to August 30, 2023, the company has repurchased 124,764 shares, representing 0.61% for KRW 299.43 million. With this, the company has completed the repurchase of 124,764 shares, representing 0.61% for KRW 299.43 million under the buyback announced on August 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,436 KRW | +5.51% | -11.36% | -44.02% |
1st Jan change | Capi. | |
---|---|---|
-44.02% | 34.53M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- A352770 Stock
- News Clinomics Inc.
- Tranche Update on Clinomics Inc.'s Equity Buyback Plan announced on August 30, 2023.